AR and prostate carcinoma: For instance, the N-terminal domain (NTD) of the androgen receptor (AR) may play a major role in gene activation [7,8], including the initiation of one aggressive form of prostate cancer: castration-resistant prostate cancer (CRPC) [9,10,11].